Nivolumab in renal cell carcinoma: latest evidence and clinical potential by Camille Mazza, Bernard Escudier, Laurence Albiges

Get full text

Hypertension and angiotensin system inhibitors in patients with metastatic renal cell carcinoma by Lisa Derosa, Hassane Izzedine, Laurence Albiges, Bernard Escudier

Get full text

Nivolumab plasma concentration and clearance associated with overall survival in patients with renal cell carcinoma by Aurélien Marabelle, Laurence Albiges, Angelo Paci, Cécile Dalban, David Combarel, Sophie Broutin, Christophe Maritaz, Louis Blondel

Get full text

Long-term complete remission with ipilimumab in metastatic castrate-resistant prostate cancer: case report of two patients by Luc Cabel, Elika Loir, Gwenaelle Gravis, Pernelle Lavaud, Christophe Massard, Laurence Albiges, Giulia Baciarello, Yohann Loriot, Karim Fizazi

Get full text

B2B: Kidney Cancer Summary by Simon Tanguay, E. Jason Abel, Laurence Albigès, Toni Choueiri, Axel Bex, Umberto Capitanio, Maxine Tran, Alessandro Volpe, Peter Black

Get full text

Body Composition to Define Prognosis of Cancers Treated by Anti-Angiogenic Drugs by Pierre Decazes, Samy Ammari, Antoine De Prévia, Léo Mottay, Littisha Lawrance, Younes Belkouchi, Baya Benatsou, Laurence Albiges, Corinne Balleyguier, Pierre Vera, Nathalie Lassau

Get full text

Vitiligo Adverse Event Observed in a Patient With Durable Complete Response After Nivolumab for Metastatic Renal Cell Carcinoma by Emilien Billon, Jochen Walz, Serge Brunelle, Jeanne Thomassin, Naji Salem, Mathilde Guerin, Cecile Vicier, Slimane Dermeche, Laurence Albiges, Florence Tantot, Soazig Nenan, Geraldine Pignot, Gwenaëlle Gravis, Gwenaëlle Gravis

Get full text

Blood-based circulating biomarkers for prediction of immune-checkpoint inhibitors efficacy in renal cell carcinoma by Loubna Omri, Marie Naigeon, Ronan Flippot, Javier Gavira-Díaz, Jesus Poveda-Ferriols, Dan Nguyen, Chaimae Abdi, Alvaro Arroyo-Salgado, Nathalie Chaput, Guillermo de Velasco, Laurence Albigès, Lucía Carril-Ajuria

Get full text

Weight and skeletal muscle loss with cabozantinib in metastatic renal cell carcinoma by Emeline Colomba, Carolina Alves Costa Silva, Gwénaël Le Teuff, Jamie Elmawieh, Daniel Afonso, Axelle Benchimol‐Zouari, Annalisa Guida, Lisa Derosa, Ronan Flippot, Bruno Raynard, Bernard Escudier, François Bidault, Laurence Albiges

Get full text

Helping patients make informed decisions. Two-year evaluation of the Gustave Roussy prostate cancer multidisciplinary clinic by Anna Patrikidou, Pierre Maroun, Jean-Jacques Patard, Hervé Baumert, Laurence Albiges, Christophe Massard, Yohann Loriot, Bernard Escudier, Mario Di Palma, Julia Arfi-Rouche, Laurence Rocher, Zahira Merabet, Alberto Bossi, Karim Fizazi, Pierre Blanchard

Get full text

Soluble BTN2A1 Is a Potential Prognosis Biomarker in Pre-Treated Advanced Renal Cell Carcinoma by Emilien Billon, Emilien Billon, Emilien Billon, Brice Chanez, Philippe Rochigneux, Philippe Rochigneux, Philippe Rochigneux, Laurence Albiges, Cécile Vicier, Géraldine Pignot, Jochen Walz, Anne-Sophie Chretien, Anne-Sophie Chretien, Gwenaelle Gravis, Daniel Olive, Daniel Olive

Get full text

B cells and the coordination of immune checkpoint inhibitor response in patients with solid tumors by Jean-Yves Scoazec, Francois-Xavier Danlos, Laurence Albiges, Bernard Escudier, Ronan Flippot, Lydie Cassard, Nathalie Chaput, Natacha Naoun, Marie Naigeon, Jean-Mehdi Jouniaux, Lisa Boselli, Lucia Carril-Ajuria, Marcus Teixeira, Macarena Rey-Cardenas, Larissa Rainho

Get full text

Survey of the Impact of COVID-19 on Oncologists’ Decision Making in Cancer by Yüksel Ürün, Syed A. Hussain, Ziad Bakouny, Daniel Castellano, Saadettin Kılıçkap, Gilberto Morgan, Rana R. Mckay, Kevin Pels, Andrew Schmidt, Deborah B. Doroshow, Fábio Schütz, Laurence Albiges, Gilberto Lopes, James W. F. Catto, Solange Peters, Toni K. Choueiri

Get full text

Comprehensive analyses of immune tumor microenvironment in papillary renal cell carcinoma by Laurence Albiges, Bernard Escudier, Gwenaelle Gravis, Ronan Flippot, Alain Ravaud, Maxime Meylan, Nathalie Rioux-Leclercq, Marine Gross-Goupil, Gaëlle Fromont, Christophe Passot, Lionnel Geoffrois, Fréderic Rolland, Manon de Vries-Brilland, Jonathan Dauvé, Elena Spirina-Menand, Christine Chevreau, Ellen Blanc, Félix Lefort, Sylvie Negrier

Get full text

Nivolumab plus ipilimumab versus sunitinib for first-line treatment of advanced renal cell carcinoma: extended 4-year follow-up of the phase III CheckMate 214 trial by Howard Gurney, Thomas Powles, Laurence Albiges, Camillo Porta, Toni K Choueiri, Marc-Oliver Grimm, Elizabeth R Plimack, Brian I Rini, Saby George, Robert J Motzer, Frede Donskov, Philippe Barthélémy, Christian K Kollmannsberger, Yoshihiko Tomita, M Brent McHenry, Shruti Shally Saggi, Nizar M Tannir, Mauricio Burotto, Daniel Castellano

Get full text

Metastatic renal cell carcinoma with occult primary: a multicenter prospective cohort by Nicolas Jacquin, Ronan Flippot, Julien Masliah-Planchon, Guillaume Grisay, Riwan Brillet, Célia Dupain, Maud Kamal, Isabelle Guillou, Nadège Gruel, Nicolas Servant, Pierre Gestraud, Jennifer Wong, Vincent Cockenpot, Andreia Goncalves, Janick Selves, Hélène Blons, Etienne Rouleau, Olivier Delattre, Claire Gervais, Christophe Le Tourneau, Ivan Bièche, Yves Allory, Laurence Albigès, Sarah Watson

Get full text

Treatment-free survival and partitioned survival analysis of patients with advanced renal cell carcinoma treated with nivolumab plus ipilimumab versus sunitinib: 5-year update of C... by Thomas Powles, Laurence Albiges, David F McDermott, Michael B Atkins, Toni K Choueiri, Bernard Escudier, Elizabeth R Plimack, Brian I Rini, Martin H Voss, Hans J Hammers, Chung-Han Lee, Robert J Motzer, Yoshihiko Tomita, Nizar M Tannir, Meredith M Regan, Charlene M Mantia, Lisa Rosenblatt, Opeyemi A Jegede

Get full text

Baseline circulating unswitched memory B cells and B-cell related soluble factors are associated with overall survival in patients with clear cell renal cell carcinoma treated with... by Laurence Albiges, Bernard Escudier, Catherine Sautes-Fridman, Benoit Beuselinck, Lydie Cassard, Maxime Meylan, Nathalie Rioux-Leclercq, Aude Desnoyer, Guillaume Lacroix, Nathalie Chaput-Gras, Marie Naigeon, Lisa Boselli, Salem Chouaib, Lucia Carril-Ajuria, Cécile Dalban, Yann Vano, Sylvie Chabaud, Janice Barros-Monteiro, Antoine Bougoüin, Irelka Colina-Moreno, Florence Tantot, Caroline De Oliveira, Wolf Herve Fridman

Get full text

Adapting the design of the ongoing RAMPART trial in response to external evidence: An example for trials which take many years to run and report by Angela Meade, Elena Frangou, Babak Choodari-Oskooei, James Larkin, Tom Powles, Grant D. Stewart, Laurence Albiges, Axel Bex, Toni K. Choueiri, Ian D. Davis, Tim Eisen, Alison Fielding, Craig Gedye, David J. Harrison, Rick Kaplan, Salena Mulhere, Paul Nathan, Grisma Patel, Jay Patel, Hannah Plant, Alastair Ritchie, Hannah Rush, Clare Shakeshaft, Martin R. Stockler, Cristina Suarez, Jemima Thompson, Nat Thorogood, Balaji Venugopal, Mahesh K.B. Parmar

Get full text

Immune checkpoints are predominantly co-expressed by clonally expanded CD4+FoxP3+ intratumoral T-cells in primary human cancers by Delphine Bredel, Edi Tihic, Séverine Mouraud, François-Xavier Danlos, Sandrine Susini, Marine Aglave, Alexia Alfaro, Chifaou Mohamed-Djalim, Mathieu Rouanne, Héloise Halse, Amélie Bigorgne, Lambros Tselikas, Stéphane Dalle, Dana M. Hartl, Eric Baudin, Catherine Guettier, Eric Vibert, Olivier Rosmorduc, Caroline Robert, Sophie Ferlicot, Bastien Parier, Laurence Albiges, Vincent Thomas de Montpreville, Benjamin Besse, Olaf Mercier, Caroline Even, Ingrid Breuskin, Marion Classe, Camélia Radulescu, Thierry Lebret, Patricia Pautier, Sébastien Gouy, Jean-Yves Scoazec, Laurence Zitvogel, Aurélien Marabelle, Mélodie Bonvalet

Get full text